AI Verdict
HBT has stronger fundamentals based on our AI analysis.
HBT vs HBIO Fundamental Comparison
| Metric | HBT | HBIO |
|---|---|---|
| Revenue | $255.8M | $86.6M |
| Net Income | $77.0M | $-56.7M |
| Net Margin | 30.1% | -65.5% |
| ROE | 12.5% | -412.8% |
| ROA | 1.5% | -70.8% |
| Current Ratio | N/A | 2.20x |
| Debt/Equity | 0.00x | 2.61x |
| EPS | $2.44 | $-1.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HBT vs HBIO: Frequently Asked Questions
Is HBT or HBIO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HBT has stronger fundamentals. HBT is rated BUY (72% confidence) while HBIO is rated STRONG SELL (92% confidence). This is not investment advice.
How does HBT compare to HBIO fundamentally?
HBT Financial, Inc. has ROE of 12.5% vs HARVARD BIOSCIENCE INC's -412.8%. Net margins are 30.1% vs -65.5% respectively.
Which stock pays higher dividends, HBT or HBIO?
HBT has a dividend yield of N/A or no dividend while HBIO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HBT or HBIO for long term?
For long-term investing, consider that HBT has BUY rating with 72% confidence, while HBIO has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HBT vs HBIO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HBT vs HBIO, the AI consensus favors HBT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.